Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.15420/icr.2016:3:1 http://scihub22266oqcxt.onion/10.15420/icr.2016:3:1 C5808498!5808498!29588709     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Interv+Cardiol 2016 ; 11 (1): 65-9 Nephropedia Template TP {{tp|p=29588709|t=2016. Interventional Therapies for Resistant Hypertension: A Brief Update |pdf=|usr=}}{{29588709}} gab.com Text Interventional Therapies for Resistant Hypertension: A Brief Update JO: Interv Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=29588709 #FOAvip Resistant hypertension remains a clinical challenge with few management options beyond maximisation of medications. Catheter- based renal artery denervation (RDN) was proposed in 2009 as a possible therapy for resistant hypertension and early feasibility trials caused excitement among cardiologists and antihypertensive specialists, showing remarkable and sustained blood pressure reductions. In 2014, enthusiasm for RDN dampened following the SYMPLICITY 3 trial results, which showed no statistically significant difference in blood pressure between the intervention and control arms. However, hope remains for the improved management of resistant hypertension; procedural understanding, technological advancements and alternative targets ? such as baroreceptor activation therapy and arteriovenous shunts ? may aid the identification of those patients for whom specific interventional therapies will be effective. Twit Text FOAVip Interventional Therapies for Resistant Hypertension: A Brief Update ????Interv Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=29588709 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29588709 #FOAvip English Wikipedia <ref>{{Cite pmid|29588709}}</ref> Interventional Therapies for Resistant Hypertension: A Brief Update #MMPMID29588709 Brandon L; Sharif F Interv Cardiol 2016[May]; 11 (1): 65-9 PMID29588709show ga Resistant hypertension remains a clinical challenge with few management options beyond maximisation of medications. Catheter- based renal artery denervation (RDN) was proposed in 2009 as a possible therapy for resistant hypertension and early feasibility trials caused excitement among cardiologists and antihypertensive specialists, showing remarkable and sustained blood pressure reductions. In 2014, enthusiasm for RDN dampened following the SYMPLICITY 3 trial results, which showed no statistically significant difference in blood pressure between the intervention and control arms. However, hope remains for the improved management of resistant hypertension; procedural understanding, technological advancements and alternative targets ? such as baroreceptor activation therapy and arteriovenous shunts ? may aid the identification of those patients for whom specific interventional therapies will be effective. äInterventional Therapies for Resistant Hypertension: A Brief Update (epmc).pdf DeepDyve Pubget Overpricing